Jane L. Wang

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Jane L. Wang, David C. Limburg, Matthew J. Graneto et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 324 citations · Full text

Medicinal Chemistry, Novel Benzopyran Class, Favorable Human Half-life +11

Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor

Gabriel Mbalaviele, Adele M. Pauley, Alexander F. Shaffer et al. · Biochemical Pharmacology · 2010 · 64 citations

Selective Mpges-1 Inhibitor, Biochemistry, Medicine +8

The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate

Jane L. Wang, Jeffery Carter, James R. Kiefer et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 48 citations · Full text

Medicinal Chemistry, Novel Benzopyran Class, Biochemistry +12

Discovery of a Simple Picomolar Inhibitor of Cholesteryl Ester Transfer Protein

Emily J. Reinhard, Jane L. Wang, Richard C. Durley et al. · Journal of Medicinal Chemistry · 2003 · 48 citations · Full text

Lower Potency, Medicinal Chemistry, Oxysterol +13

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates

Jane L. Wang, Karl Aston, David C. Limburg et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 36 citations · Full text

Medicinal Chemistry, Novel Benzopyran Class, Pharmaceutical Chemistry +12